| Multifunctional bio‐nanocomposite coatings for perishable fruits S Jung, Y Cui, M Barnes, C Satam, S Zhang, RA Chowdhury, ... Advanced Materials 32 (26), 1908291, 2020 | 237 | 2020 |
| Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors AM Nash, MI Jarvis, S Aghlara-Fotovat, S Mukherjee, A Hernandez, ... Science advances 8 (9), eabm1032, 2022 | 52 | 2022 |
| Corrosion resistance of sulfur–selenium alloy coatings S Susarla, G Chilkoor, JR Kalimuthu, M Saadi, Y Cui, T Arif, T Tsafack, ... Advanced Materials 33 (51), 2104467, 2021 | 36 | 2021 |
| Antigen discovery for the development of cancer immunotherapy R Ahn, Y Cui, FM White Seminars in Immunology 66, 101733, 2023 | 13 | 2023 |
| Development of serum-free media for cryopreservation of hydrogel encapsulated cell-based therapeutics Y Cui, AM Nash, B Castillo, LD Sanchez Solis, S Aghlara-Fotovat, ... Cellular and Molecular Bioengineering 15 (5), 425-437, 2022 | 5 | 2022 |
| Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression M Roerden, AB Castro, Y Cui, N Harake, B Kim, J Dye, L Maiorino, ... Journal for ImmunoTherapy of Cancer 12 (11), e010249, 2024 | | 2024 |
| 897 Quantitative cell type specific immunopeptidome analysis of macrophage: tumor interface in glioblastoma Y Cui, KH Phuong, L Maiorino, B Kim, J Dye, D Irvine, F White Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
| Validation and quantification of peptide antigens presented on MHCs using SureQuant O Leddy, Y Cui, R Ahn, L Stopfer, E Choe, DH Kim, M Roerden, ... Nature Protocols, 1-27, 2024 | | 2024 |
| Structural and systems characterization of phosphorylation on metabolic enzymes identifies sex-specific metabolic reprogramming in obesity TY Tamir, S Chaudhary, AX Li, SE Trojan, CT Flower, P Vo, Y Cui, ... bioRxiv, 2024 | | 2024 |
| Uncovering the signaling networks of disseminated glioblastoma cells in vivo with INSIGHT R Ahn, AD D'Souza, L Long, Y Cui, D Burgenske, KK Bakken, LL Ott, ... bioRxiv, 2024.12. 04.626717, 2024 | | 2024 |
| 929 Mutual interactions between neoantigen-specific CD8+ T cell responses facilitate immune evasion in sub-clonal tumors M Roerden, N Harake, B Kim, Y Cui, F White, D Irvine, S Spranger Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Tumor Adjacent IL2 Cytokine Factories Eradicates Ovarian Cancer in Mice Through Cytotoxic T-cell Activation with Safe and Predictable Dosing in Non-human Primates G Carmona, A Nash, M Jarvis, R Newman, J Schladenhauffen, ... The Journal of Immunology 208 (Supplement_1), 122.17-122.17, 2022 | | 2022 |
| Tumor Adjacent IL-2 Cytokine Factories for Eradication of Various Solid Tumor in Mice Through Cytotoxic T-cell Activation with Safe and Predictable Dosing in Non-Human Primates G Carmona, A Nash, R Newman, J Schladenhauffen, M Jarvis, ... MOLECULAR THERAPY 30 (4), 309-309, 2022 | | 2022 |
| Sub-clonal tumors and NeoAgs M Roerden, AB Castro, Y Cui, N Harake, B Kim, J Dye | | |